Study: Out-of-pocket EpiPen spending jumps 124% in 7 years

(By Mackenzie Bean for Becker’s Hospital Review)

The amount patients pay out-of-pocket for Mylan’s life-saving EpiPen device increased drastically since 2007, according to a study in JAMA Internal Medicine. Continue reading article here…

Notice: The link provided above connects readers to the full content of the posted article. The URL (internet address) for this link is valid on the posted date; medicarereport.org cannot guarantee the duration of the link’s validity. Also, the opinions expressed in these postings are the viewpoints of the original source and are not explicitly endorsed by AMAC, Inc.; the AMAC Foundation, Inc.; or medicarereport.org.